PubPharm Blog
Figure 18 to the question “Which advantages of the Drug-Target-Disease Networks are most relevant for you?” (x=22 – total number of answers; multiple answers were possible)
You must be logged in to post a comment.
Questions or suggestions – please write to: pubpharm[at]tu-braunschweig.de